
Work Here?
Gooch & Housego PLC designs, tests, and manufactures optical components and assemblies for demanding applications. Its products cover acousto-optic, electro-optic, crystal-optic, fibre optic, and precision optic technologies, enabling customized optical systems for life sciences, industrial, and aerospace/defence customers. The company’s offerings work by integrating specialized optical components into turnkey systems and subsystems tailored to user needs, backed by in-house design, testing, and manufacturing capabilities. G&H differentiates itself through a broad portfolio of optical technologies and a long track record (over 75 years) across global operations in the UK, USA, and Europe, making it a trusted supplier for original equipment manufacturers. Its goal is to be the preferred source for OEMs by delivering consistent quality, performance, and reliability across its optical products and solutions.
Industries
Industrial & Manufacturing
Aerospace
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Ilminster, United Kingdom
Founded
1948
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$9.8M
Above
Industry Average
Funded Over
2 Rounds
Paid Holidays
Performance Bonus
Employee Referral Bonus
Remote Work Options
Greenlight Bidco Limited, indirectly owned by Arlington Capital Partners VII, has announced a recommended cash acquisition of Gooch & Housego for 1,234.9 pence per share. This comprises 1,230.0 pence in cash and a 4.9 pence interim dividend. The offer values the photonics engineering company at approximately £345.6 million on a fully diluted basis. It represents a premium of approximately 40.7% to the closing share price on 15 July 2026. The board of Gooch & Housego unanimously recommends shareholders vote in favour of the scheme of arrangement. The acquisition is expected to complete in the fourth quarter of 2026, subject to regulatory approvals and shareholder consent. Arlington Capital Partners brings experience investing in aerospace, defence, and life sciences sectors where Gooch & Housego operates.
G&H to showcase quantum-enabling photonics technologies at Optica Quantum 2.0 2026. June 2026 - Glasgow, UK G&H (LON: GHH), a global leader in optics and photonics technology, will showcase its advanced quantum-enabling technologies at the Optica Quantum 2.0 Conference and Exhibition, taking place 15-18 June 2026 at the Scottish Event Campus (SEC) in Glasgow, UK. Visitors can meet the G&H team at Booth #115. Co-located with the Optica 2026 Quantum Industry Summit - Fifth Edition, Quantum 2.0 brings together researchers, technology developers, and commercial leaders working to accelerate the transition of quantum technologies from laboratory research to real-world deployment. As quantum architectures continue to scale in complexity, photonics has become increasingly critical to enabling precise control, measurement, communication, and computation. G&H supports customers across the quantum ecosystem with a broad portfolio of acousto-optic, electro-optic, fiber-optic, and precision optical technologies, combined with the manufacturing expertise required to transition innovations from prototype to production. At the exhibition, G&H will highlight technologies supporting quantum computing, quantum communications, quantum sensing, quantum metrology, and emerging quantum-enabled systems. "Quantum technologies are moving rapidly from proof-of-concept demonstrations toward scalable, deployable systems," said Richard Hendel, Head of Global Sales, Photonics. "As this transition occurs, the need for precision photonic infrastructure becomes increasingly important. G&H combines decades of photonics expertise with scalable manufacturing capabilities to help customers overcome the challenges associated with building practical quantum systems."
Somerset-based photonics engineering firm Gooch & Housego has secured $10 million from NatWest, bringing the bank's total backing to $70 million (£52 million). The Ilminster company will use the fresh funding to stock up on crucial materials like germanium, increase manufacturing capacity and strengthen its supply chain. The investment marks continued support for the photonics specialist as it scales operations. No further details about the company's valuation or revenue were disclosed.
NatWest backs Ilminster firm with £10m funding
G&H showcases photonics-enabled diagnostic innovation at ESCMID 2026. March 2026 April 2026 - Ashford, UK G&H (LON:GHH), a global leader in life sciences manufacturing, optics, and photonics, will exhibit at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2026), taking place April 18-21 at Messe München in Munich, Germany. Attendees can visit G&H at Hall B1, Booth #D12 to explore how the company enables next-generation infectious disease diagnostics through its vertically integrated medical device development capabilities, delivered through its life sciences business, G&H | ITL.
Find jobs on Simplify and start your career today
Industries
Industrial & Manufacturing
Aerospace
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Ilminster, United Kingdom
Founded
1948
Find jobs on Simplify and start your career today